Royal Marsden Nhs Foundation Trust

This study tested the safety of combining two drugs, pembrolizumab and gemcitabine, in patients with advanced forms of sarcoma called leiomyosarcoma and undifferentiated pleomorphic sarcoma. The main goal was to find the highest dose of gemcitabine that could be safely given with…

This study tested whether a drug called crizotinib, used for some lung cancers, could help control advanced lobular breast cancer and certain other hard-to-treat cancers. For breast cancer patients, it was combined with a hormone-blocking drug called fulvestrant. The main goal wa…

This early-stage trial tested a new oral drug, VS-6766, given alone and later combined with another drug called everolimus. The main goal was to find safe and tolerable dosing schedules for patients with advanced solid tumors or multiple myeloma that had stopped responding to sta…

This study aimed to understand how COVID-19 affects people with cancer, who may be at higher risk. Researchers followed 153 patients to track their infection and measure their antibody levels over time. The goal was to gather information to help doctors make better decisions abou…